NGENEBIO USA HOLDINGS, INC., announced that it has issued 2,700 common shares at an issue price of KRW 1,385,000 per share for gross proceeds of KRW 3,739,500,000 on April 22, 2024. The transaction included participation from returning investor, NGeneBio Co., Ltd. for 3,000 shares for post-investment stake of 100%. The transaction has been approved by board of directors of the company.

The method of capital increase is through shareholder allocation. The transaction is expected to close on April 23, 2024.